Dabrafenib
Showing 151 - 171 of 171
Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC Trial in France (immune-checkpoint inhibitors therapies)
Unknown status
- Advanced or Metastatic Melanoma
- Advanced or Metastatic NSCLC
- immune-checkpoint inhibitors therapies
-
Marseille, Bouches Du Rhône, France
- +8 more
Sep 25, 2019
Melanoma, Malignant, of Soft Parts Trial in Netherlands (Vemurafenib and Cobimetinib)
Recruiting
- Melanoma, Malignant, of Soft Parts
- Vemurafenib and Cobimetinib
-
Amsterdam, Netherlands
- +12 more
Jun 3, 2020
Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)
Unknown status
- Metastatic Cancer
- Non Chemotherapy
- +2 more
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019
Unresectable Stage III and Metastatic Melanoma in United States
Completed
- Melanoma
- Non-Interventional
-
Morristown, New JerseyLocal Institution
Feb 5, 2018
Melanoma Trial in Houston (GSK2118436, GSK1120212)
Completed
- Melanoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 19, 2016
Cancer Trial in Australia, United Kingdom, United States (GSK2118436 75 mg, Placebo)
Completed
- Cancer
- GSK2118436 75 mg
- Placebo
-
Scottsdale, Arizona
- +7 more
Nov 8, 2017
After Vemurafenib / BRAF Inhibitors Interruption in
Unknown status
- Erdheim-Chester Disease
-
New York, New York
- +1 more
Oct 27, 2016
Melanoma (Skin) Trial in Amiens (Development of the most specific physiologically relevant experimental patient models)
Unknown status
- Melanoma (Skin)
- Development of the most specific physiologically relevant experimental patient models
-
Amiens, Picardie, FranceCHU Amiens Picardie
Apr 28, 2017
Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)
Completed
- Atrial Fibrillation
- Marevan®
- +2 more
-
São Paulo, BrazilHospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016
Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,
Terminated
- Recurrent Melanoma
- +4 more
- Akt inhibitor MK2206
- +2 more
-
Atlanta, Georgia
- +3 more
May 16, 2014
Melanoma and Brain Metastases Trial in Worldwide (GSK2118436)
Completed
- Melanoma and Brain Metastases
-
Los Angeles, California
- +23 more
Apr 24, 2014